科言猫
学术研究的AI总结
首页
文献互助
订阅
我的收藏
科研工具
选题分析
论文总结
专利管理
专利缴费
专利查询
未登录
返回
期刊详情
Trends in Cancer
IF
17.5
论文数
1193
被引数
9356
相关解读
0
订阅
期刊论文
1193
相关解读
0
期刊论文
1193
发表时间
发表时间
IF
被引数
Genome-wide human T cell screens: barriers and design
全基因组人类T细胞筛选:障碍与设计
Trends in Cancer
IF
17.5
2026-10-24
0
PRE
AI
Jie Zhong; Jiajia Wang; Chen Wang; Lianjun Zhang
分享
收藏
Advancing functional treatment prediction for precision oncology
推进功能治疗预测以实现精准肿瘤学
Trends in Cancer
IF
17.5
2026-10-21
0
OA
AI
Eveline C. Smit; Zofia M. Komar; Hedwig M. Blommestein; Henk M.W. Verheul; Agnes Jager; Daniele V.F. Tauriello; Dik C. van Gent
分享
收藏
The tumor macroenvironment as cancer metabolism’s next frontier
肿瘤微环境作为癌症代谢的下一个前沿
Trends in Cancer
IF
17.5
2026-10-20
0
OA
AI
Allison B. Grenell; Joe L. Rowles; Ronnie Fowle-Grider; Yin Cao; Leah P. Shriver; Gary J. Patti
分享
收藏
Bispecific antibodies in NSCLC: immune reengineering to neutralize adaptive tumor resistance
NSCLC中的双特异性抗体:免疫重构以中和适应性肿瘤耐药性
Trends in Cancer
IF
17.5
2026-10-20
0
PRE
AI
Zetong Li; Haowei Wang; Meng Diao; Ruixuan Liu; Xinyao Wang; Anwen Xiong; Caicun Zhou; Zhuoran Tang
分享
收藏
MAIT cells in gastrointestinal cancer: immunity to therapy
MAIT细胞在胃肠道癌症中的作用:从免疫到治疗
Trends in Cancer
IF
17.5
2026-10-19
0
OA
AI
Yan-Ruide Li; Yuning Chen; Shelby Yeh; Thomas Yuen; Lili Yang
分享
收藏
Emerging landscape of antibody–drug conjugates in lung cancer: a clinical review
肺癌中抗体-药物偶联物的最新进展:一项临床综述
Trends in Cancer
IF
17.5
2026-10-14
0
OA
AI
Henry Pickett; Javier Arias-Romero; Jeremy Fricke; Isa Mambetsariev; Neil Chen; Debora S. Bruno; Matthew Lee; Arya Amini; Jyoti Malhotra; Ravi Salgia
分享
收藏
Enhancer of zeste homolog 2 links epigenetic plasticity to cholesterol metabolism
组蛋白甲基转移酶EZH2将表观遗传可塑性连接到胆固醇代谢
Trends in Cancer
IF
17.5
2026-10-08
0
PRE
AI
Cheng Wang; Hongwen Zhu; Xiongjun Wang
分享
收藏
Protecting axonal mitochondria prevents chemotherapy-driven neuropathy
保护轴突线粒体可预防化疗诱导的神经病变
Trends in Cancer
IF
17.5
2026-10-08
0
PRE
AI
Lorenzo Galluzzi; Jorge Gómez-Deza
分享
收藏
Trends in Cancer
IF
17.5
2026-09-22
0
PRE
AI
Rachel S. Sousa; Alexander Moshensky; Claire Murat; Shannon N. Geels; John Lowengrub; Francesco Marangoni
分享
收藏
Circulating Tumor Cell–Immune Cell Clusters: Dynamic Engines of Metastasis
循环肿瘤细胞–免疫细胞簇:转移的动态引擎
Trends in Cancer
IF
17.5
2026-09-22
0
PRE
AI
Fangjia Tong; Xin Liu; Deyu Fang; Patricia A. Robinson; William J. Gradishar; Rongfu Wang; Huiping Liu
分享
收藏
Macrophage-directed therapeutic strategies in cancer
靶向巨噬细胞的癌症治疗策略
Trends in Cancer
IF
17.5
2026-09-21
0
PRE
AI
Shweta Joshi; Judith Varner
分享
收藏
Lkb1 loss links dietary lipids to cancer cachexia
Lkb1缺失将饮食脂质与癌症恶病质联系起来
Trends in Cancer
IF
17.5
2026-09-15
0
PRE
AI
Xiaolin Liu; Jiayi Shen; Gaofei Wei
分享
收藏
Heterotypic tumor microenvironments mirror dynamic wound-healing process
异质性肿瘤微环境镜像动态伤口愈合过程
Trends in Cancer
IF
17.5
2026-09-10
0
PRE
AI
Liqun Yu; Xiang H.-F. Zhang
分享
收藏
Cancer-associated synonymous mutations target mRNA structures and protein activity
癌症相关的同义突变靶向mRNA结构和蛋白质活性
Trends in Cancer
IF
17.5
2026-09-08
0
OA
AI
Robin Fahraeus
分享
收藏
Exploiting DNA damage tolerance for precision oncology
利用DNA损伤耐受性进行精准肿瘤学治疗
Trends in Cancer
IF
17.5
2026-09-05
0
OA
AI
Audesh Bhat; Ganesh P. Lahane; Raj K. Pandita; Albino Bacolla; Bettina Hoden; Kenneth S. Ramos; Sunil Krishnan; Partha S. Sarkar; Arti Dhar; John A. Tainer; Tej K. Pandita
分享
收藏
Host metabolism rewrites metastatic fate
宿主代谢重写转移命运
Trends in Cancer
IF
17.5
2026-09-03
0
PRE
AI
Zihan Qiu; Xinyu Li; Pengfei Xu
分享
收藏
RBM15 in leukemogenesis: an emerging regulator at the interface of RNA biology and hematopoiesis
RBM15在白血病发生中的作用:RNA生物学与造血系统交叉点的新兴调控因子
Trends in Cancer
IF
17.5
2026-09-02
0
PRE
AI
Jether Amos Espinosa; Madeline Y. Mayday; Abigail R. Robb; Gina Lee; Diane S. Krause
分享
收藏
Accelerating rare cancer research: a Zebrafish-First Triage Strategy
加速稀有癌症研究:一种斑马鱼优先的筛选策略
Trends in Cancer
IF
17.5
2026-08-28
0
OA
AI
Bruno Lopes-Bastos; Ewa Snaar-Jagalska
分享
收藏
Cancer cell plasticity: new insights from developmental programs
癌细胞可塑性:来自发育程序的新的见解
Trends in Cancer
IF
17.5
2026-08-22
0
PRE
AI
Vincent J. Guen; Robert A. Weinberg
分享
收藏
Drugging the undruggable: early phase trial shows trabectedin and low-dose irinotecan downregulate EWSR1::FLI1 and has clinical activity in advanced Ewing sarcoma
靶向“不可成药”靶点:早期临床试验表明,曲贝替定和低剂量伊立替康可下调EWSR1::FLI1,并对晚期尤因肉瘤具有临床活性
Trends in Cancer
IF
17.5
2026-08-21
0
PRE
AI
David S. Shulman; Katherine A. Janeway
分享
收藏